Biotech News

Emergent BioSolutions Participates in Upcoming International Preparedness Conferences

Emergent BioSolutions (EBS)Emergent BioSolutionsCompany update

GAITHERSBURG, Md., April 02, 2026 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS), a global life sciences leader with biodefense and medical countermeasures products, announced today that members of its products business, medical affairs, government and public affairs teams will

Related news

Emergent BioSolutions

Emergent BioSolutions is a biodefense and specialty products company focused on public-health preparedness, vaccines, and medical countermeasures. Its business is centered on government and specialty healthcare contracts.

Recent company news

Stock data

Close
4.82 USD
Market cap
423.61M USD
Exchange
NYSE
Sector
Biopharma
Location
United States